These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28064562)

  • 1. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease: How Are They Changing in Response to Efforts to Control Them?
    Snyder E; Credille B
    Vet Clin North Am Food Anim Pract; 2020 Jul; 36(2):253-268. PubMed ID: 32327253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
    Sweeney MT; Brumbaugh GW; Watts JL
    Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017.
    Holschbach CL; Aulik N; Poulsen K; Ollivett TL
    J Dairy Sci; 2020 Oct; 103(10):9464-9472. PubMed ID: 32747101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
    Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
    J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
    Shryock TR; White DW; Staples JM; Werner CS
    J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle.
    Schwarz S; Kehrenberg C; Salmon SA; Watts JL
    J Antimicrob Chemother; 2004 Feb; 53(2):379-82. PubMed ID: 14729757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
    Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
    PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in fluoroquinolone pharmacodynamic parameter values among isolates of two bacterial pathogens of bovine respiratory disease.
    Wen X; Gehring R; Riviere JE; Lubbers BV; Gaire TN; Wyche B; Fox B; Quichocho V; Volkova VV
    Sci Rep; 2018 Jul; 8(1):10553. PubMed ID: 30002424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
    Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
    Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of florfenicol for calf pneumonia pathogens.
    Illambas J; Potter T; Sidhu P; Rycroft AN; Cheng Z; Lees P
    Vet Rec; 2013 Mar; 172(13):340. PubMed ID: 23482237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth media.
    Mead A; Lees P; Mitchell J; Rycroft A; Standing JF; Toutain PL; Pelligand L
    J Vet Pharmacol Ther; 2019 Jan; 42(1):52-59. PubMed ID: 30267412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.
    Harada K; Usui M; Asai T
    J Vet Med Sci; 2014 Oct; 76(10):1427-30. PubMed ID: 25008965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in bovine respiratory disease: Auction market- and ranch-raised calves.
    Wennekamp TR; Waldner CL; Windeyer MC; Larson K; Trokhymchuk A; Campbell JR
    Can Vet J; 2022 Jan; 63(1):47-54. PubMed ID: 34975167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.